Gevo stock
GEVONASDAQGevo, Inc., Basic MaterialsISIN US3743964062
42Score 42 out of 100, Weak
Price and trend
63 / 100
Price history
−12% in one yearThe chart shows daily closes over 16 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 10% above it.
Since May 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Overheated: the price has risen very quickly lately (RSI 79).
The price is 33% below its 52-week high. Largest decline in 16 years: 100% (April 2011 to July 2020).
Chart figures for advanced users
- SMA 50$1.37
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$1.69
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)79
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$1.11
- The lowest closing price of the last twelve months.
- Resistance$2.78
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Gevo, Inc. belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $459.86M, is number 101 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $160.58M (up 849.3% year on year) and a loss of $33.84M.
- For fiscal 2026, analysts expect on average revenue of $196.46M (up 22.3%) and adjusted earnings per share of −$0.04.
Show more
- MEQIRI Score 42 out of 100 (Weak): rank 383 of 467 in Basic Materials, median 58.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 96.1% a year since 2020, Chemicals (Specialty) median 6%.Growth 70
Weaknesses
- Loss-makingLoss of $182.22M over the last 12 months.Fundamentals 17
- DilutionShare count up 20% since 2021.Capital allocation 23
- Volatile share priceVolatility 71% a year over the last 12 months.Stability 47
Its standout strength is growth, while capital allocation and fundamentals hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 38 to 42.
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansValuation
Valuation signal
not measuredClosing price of 11 Nov 2026, used by the daily score.
A fair value is not meaningful here, so the signal follows the valuation grade.
Valuation metrics
The model puts the fair value at more than four times the share price. That says more about the assumptions than about the company, so a fair value is not meaningful here and the valuation relies on the P/E and the other metrics.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
Revenue has grown strongly since 2007, at around 42% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 30%, operating −12%, net −21%. Last 12 months: net −84%.
Debt & balance sheet
latest quarterDebt is moderate, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 4 Mar 2027in 112 days
- Last reported
- 10 Nov 2026EPS reported $0.09 (expected $0.04)above expectations
Analyst estimates
Earnings estimates have barely changed since 6 Nov 2026.
- Earnings per share
- −$0.040.0%
- Revenue
- $196.46M0.0%
- Earnings per share
- $0.000.0%
- Revenue
- $208.18M0.0%
MEQIRI has stored the estimates since 6 Nov 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Insiders
Open-market purchases and sales by executives, board members and major holders
2 insiders bought on the open market in the last 6 months, $96,369 in total. 7 insiders sold, $1.7M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Bowron Kimberly TSale
3 Sept 2026, Chief of Staff
- Shares
- 1,221
- Price
- $1.71
- Value
- $2,088
- Bloom Paul DSale
3 Sept 2026, CEO
- Shares
- 1,514
- Price
- $1.71
- Value
- $2,589
- Gruber Patrick R.Sale
3 Sept 2026, Board
- Shares
- 3,333
- Price
- $1.70
- Value
- $5,671
Show 19 more
- Kettner David MichaelPurchase
21 Aug 2026, Chief Legal & Emrg Biz Officer
- Shares
- 12,500
- Price
- $1.55
- Value
- $19,369
- Barber James JPurchase
21 Aug 2026, Board
- Shares
- 50,000
- Price
- $1.54
- Value
- $77,000
- Gruber Patrick R.Sale
6 Aug 2026, Board
- Shares
- 247,642
- Price
- $1.51
- Value
- $373,816
- Bowron Kimberly TSale
6 Aug 2026, Chief of Staff
- Shares
- 10,257
- Price
- $1.55
- Value
- $15,855
- Agiri Oluwagbemileke YusufSale
6 Aug 2026, CFO
- Shares
- 18,223
- Price
- $1.54
- Value
- $28,034
- Bloom Paul DSale
6 Aug 2026, CEO
- Shares
- 31,096
- Price
- $1.55
- Value
- $48,068
- Gruber Patrick R.Sale
12 Jun 2026, Board
- Shares
- 157,563
- Price
- $1.40
- Value
- $220,856
- Agiri Oluwagbemileke YusufSale
12 Jun 2026, CFO
- Shares
- 63,028
- Price
- $1.40
- Value
- $88,075
- Bowron Kimberly TSale
12 Jun 2026, Chief of Staff
- Shares
- 15,470
- Price
- $1.43
- Value
- $22,048
- Gendenjamts DavaajargalSale
12 Jun 2026, VP Acctg and Treasurer
- Shares
- 4,293
- Price
- $1.43
- Value
- $6,118
- Shafer AndrewSale
12 Jun 2026, Chief Mktg Cust & Brnd Officer
- Shares
- 9,443
- Price
- $1.43
- Value
- $13,458
- Ryan Christopher MichaelSale
12 Jun 2026, President & COO
- Shares
- 35,196
- Price
- $1.43
- Value
- $50,161
- Bloom Paul DSale
12 Jun 2026, CEO
- Shares
- 35,189
- Price
- $1.43
- Value
- $50,151
- Gruber Patrick R.Sale
27 May 2026, Board
- Shares
- 186,469
- Price
- $1.76
- Value
- $328,148
- Shafer AndrewSale
27 May 2026, Chief Mktg Cust & Brnd Officer
- Shares
- 32,667
- Price
- $1.76
- Value
- $57,487
- Bowron Kimberly TSale
27 May 2026, Chief of Staff
- Shares
- 25,101
- Price
- $1.76
- Value
- $44,173
- Agiri Oluwagbemileke YusufSale
27 May 2026, CFO
- Shares
- 31,958
- Price
- $1.77
- Value
- $56,652
- Ryan Christopher MichaelSale
27 May 2026, President & COO
- Shares
- 87,700
- Price
- $1.76
- Value
- $154,334
- Bloom Paul DSale
27 May 2026, CEO
- Shares
- 75,735
- Price
- $1.76
- Value
- $133,278
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Gevo
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 42
- Sector median
- 58
Categories against the sector medianMedian of 467 companies
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Koppers HoldingsKOP $587.58M41
- Lightwave LogicLWLG $547.29M29
- Aspen AerogelsASPN $532.85M45
- Plastika KritisPLAKR.AT $463.07M67
- AdvanSixASIX $416.74M42
- Rayonier Advanced MaterialsRYAM $374.07M26
- Uzin UtzUZU.DE $365.96M55
- ASP IsotopesASPI $300.49M27
ETFs that hold Gevo
Held by 4 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Amundi Global Bioenergy UCITS ETF EUR AccWDNR | 0.27% | 0.35% | €151.65M |
| iShares Global Clean Energy Transition UCITS ETFIQQH | 0.21% | 0.65% | €2.49B |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.01% | 0.30% | €4.22B |
Show 1 more
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.01% | 0.30% | €2.17B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 29 Feb 2012)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.